SCHEMBL14138555

SCHEMBL14138555

O=Cc1cc(-c2ccc(O)cc2)on1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.57
TP53 P04637 1/20 0.49
NPC1 O15118 7/20 0.48
RAB9A P51151 7/20 0.48
POLB P06746 2/20 0.48
ESR1 P03372 1/20 0.46
ESR2 Q92731 1/20 0.46
HSD17B1 P14061 1/20 0.45
HSD17B2 P37059 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4886228 0.82 NPC1 (0.51) ALDH1A1TP53NPC1RAB9APOLB
SCHEMBL11902032 0.82 PTPN1 (0.56) ALDH1A1TP53NPC1RAB9APOLB
SCHEMBL1959876 0.82 PTGS2 (0.48) ALDH1A1TP53NPC1RAB9ATDP1
SCHEMBL11902664 0.82 NPC1 (0.51) ALDH1A1TP53NPC1RAB9APOLB
SCHEMBL189929 0.81 RAB9A (0.55) ALDH1A1NPC1RAB9APOLBTDP1
SCHEMBL14138588 0.81 HSD17B1 (0.56) ALDH1A1TP53NPC1RAB9AHSD17B1
SCHEMBL27710152 0.78 TAAR1 (0.41) ALDH1A1TP53NPC1RAB9ATDP1
SCHEMBL1957272 0.78 HPGD (0.59) ALDH1A1TP53NPC1RAB9AKMT2A
SCHEMBL8375802 0.75 ALDH1A1 (0.61) ALDH1A1TP53NPC1RAB9APOLB
SCHEMBL4135779 0.74 ERN1 (0.41) HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008079277-A1 CERTAIN PYRAZOLINE DERIVATIVES WITH KINASE INHIBITORY ACTIVITY MILLENNIUM PHARMACEUTICALS, INC. (US) 2008-07-03 WO disclosed